Comparison Between Free Gingival Graft and Palatal Pedicle Flap (Pedicle)
Comparison of Keratinized Mucosa Width Increase Around Implants Between Palatal Pedicle Flap and Free Gingival Graft: a Clinical Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The present prospective clinical controlled trial included patients with at least one implant requiring stage 2 surgery. All implant surgeries were performed by the same surgeon (CYL) from 2021 July to 2023 January. All included patients had to meet the following inclusion criteria:
- Patient had at least one bone-level 3i implant*: 3.25, 4, and 5 mm in diameter, 8.5, 10, and 11.5 mm in length, and primary stability with an insertion torque ≥ 20Ncm. All implants needed to be free of peri-implant disease.
- Informed consent had been obtained prior to implant uncovering.
- Insufficient keratinized mucosal width (KMW< 2mm) was observed
- Complete data, including both clinical and radiographic outcomes, was available
- The patient followed the supportive postimplant regimen for a 12-month loading period, indicating good compliance.
Patients were excluded from this project if they have one of the following conditions:
- Untreated periodontitis.
- Uncontrolled systemic disease, such as hypertension, diabetes, and heavy smokers (more than 10 pieces per day).
- History of radiation therapy on head and neck regions.
- Patient with pregnancy
- Patient had pathologic lesions around peri-implant mucosa
- Guided bone regeneration was needed concomitantly with soft tissue phenotype modification during uncovering surgery.
Following the revised version of Helsinki Declaration in 2013, the protocol of current trial was conducted and approved by institutional review board of Chang Gung memorial hospital (IRB: 202100738A3). The cohort study was performed in accordance with STROBE statement.
2.2 Clinical Procedures Under local anesthesia, either APF combined with FGG or PPF with xenogenic matrix was performed around implants for KMW enhancement, which was concomitant with uncovering surgery.
In APF + FGG technique, a split- thickness flap was prepared and apically positioned using 5-0 (PDS*II, Polydioxanone, ETHICON) or 6-0 (PROLENE, ETHICON) sutures for flap stabilization. To eliminate muscle and frenum attachment at recipient site, vestibuloplasty and a periosteal incision were performed. A 4 mm or 6 mm healing abutment was then screwed onto the implants. FGG was harvested from palate in a 7-8 mm width and trimmed to an even thickness of 1 to 1.5 mm. A resorbable hemostatic sponge (Spongostan, Ethicon, Johnson & Johnson) was placed at donor site for wound coverage. For graft fixation, a loop suture with 6-0 (PROLENE, ETHICON) was first placed at the center of recipient site, additional sutures were added to enhance stabilization.
For the PPF group, the palatal sliding flap was a modified version of modified roll technique, as described in previous cohort study. Unlike the original technique, the crestal incision was placed 5 mm palatally from the border of keratinized tissue to allow for KMW redistribution, and a partially split-thickness flap was harvested from palatal connective tissue graft (CTG). Following buccal pouch flap preparation, a slight APF was required in cases with limited vestibular depth. When the palatal pedicle CTG was rolled in buccal pouch flap, a loop suture with 6-0 (PROLENE, ETHICON) was used for flap stabilization. The exposed connective tissue bed or bone around the implants was covered with a dual- layered collagen matrix (Lyoplant®Onlay, Aesculap), and additional sutures were used for graft and flap fixation. The specific indications for the PPF technique were shown as below: (1) the total keratinized mucosa width should be more than 3 mm; (2) the vertical soft tissue height should be more than 2 mm at the time of the uncovering surgery.
Post-operative instructions were instructed individually, and the medications were prescribed (acetaminophen 500 mg, tid for 5 days; amoxicillin 375 mg, tid for 5 days) for pain and infection control during post-operative phase. Two weeks after surgery, sutures were removed, and surgical wounds were followed at recall visit 2 months later. The implant prosthesis was then restored by prosthodontic specialists. The clinical and radiographic data were collected at 3, 6, and 12 months after loading during a strict maintenance period, which involved a 3-month interval over the course of 12 months. According to the supportive strategy, routine coronal prophylaxis with ultrasonic device and titanium curettes was applied, and oral hygiene reinforcement with adequately interdental brush and superfloss was instructed at every visit.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 105
- Taipei Chang Gung Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient had at least one bone-level 3i implant*: 3.25, 4, and 5 mm in diameter, 8.5, 10, and 11.5 mm in length, and primary stability with an insertion torque ≥ 20Ncm. All implants needed to be free of peri-implant disease.
- Informed consent had been obtained prior to implant uncovering.
- Insufficient keratinized mucosal width (KMW< 2mm) was observed
- Complete data, including both clinical and radiographic outcomes, was available
- The patient followed the supportive postimplant regimen for a 12-month loading period, indicating good compliance.
Exclusion Criteria:
- Untreated periodontitis.
- Uncontrolled systemic disease, such as hypertension, diabetes, and heavy smokers (more than 10 pieces per day).
- History of radiation therapy on head and neck regions.
- Patient with pregnancy
- Patient had pathologic lesions around peri-implant mucosa
- Guided bone regeneration was needed concomitantly with soft tissue phenotype modification during uncovering surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: FGG group
In APF + FGG technique, a split- thickness flap was prepared and apically positioned using 5-0 (PDS*II, Polydioxanone, ETHICON) or 6-0 (PROLENE, ETHICON) sutures for flap stabilization.
|
In APF + FGG technique, a split- thickness flap was prepared and apically positioned using 5-0 (PDS*II, Polydioxanone, ETHICON) or 6-0 (PROLENE, ETHICON) sutures for flap stabilization.
To eliminate muscle and frenum attachment at recipient site, vestibuloplasty and a periosteal incision were performed.
A 4 mm or 6 mm healing abutment was then screwed onto the implants.
FGG was harvested from palate in a 7-8 mm width and trimmed to an even thickness of 1 to 1.5 mm.
A resorbable hemostatic sponge (Spongostan, Ethicon, Johnson & Johnson) was placed at donor site for wound coverage.
For graft fixation, a loop suture with 6-0 (PROLENE, ETHICON) was first placed at the center of recipient site, additional sutures were added to enhance stabilization.
Other Names:
|
|
Active Comparator: Palatal pedicle flap with collagen matrix
For thepalatal pedicle flap with collagen matrix (PPF) group, the palatal sliding flap was a modified version of modified roll technique, the crestal incision was placed 5 mm palatally from the border of keratinized tissue to allow for KMW redistribution, and a partially split-thickness flap was harvested from palatal connective tissue graft (CTG).
|
For the PPF group, the palatal sliding flap was a modified version of modified roll technique, as described in previous cohort study.
Unlike the original technique, the crestal incision was placed 5 mm palatally from the border of keratinized tissue to allow for KMW redistribution, and a partially split-thickness flap was harvested from palatal connective tissue graft (CTG).
Following buccal pouch flap preparation, a slight APF was required in cases with limited vestibular depth.
When the palatal pedicle CTG was rolled in buccal pouch flap, a loop suture with 6-0 (PROLENE, ETHICON) was used for flap stabilization.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Keratinized mucosal width amount(mm)
Time Frame: at 2 weeks (2W) and 2 months (2M), 3 months (3ML), and 6 months after loading (6ML)
|
Keratinized mucosal width amount(mm) was measured with periodontal probe from mucosal margin to mucosogingival junction
|
at 2 weeks (2W) and 2 months (2M), 3 months (3ML), and 6 months after loading (6ML)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mucosal recession (REC, mm)
Time Frame: at 2 months (2M), 3 months (3ML), and 6 months after loading (6ML)
|
The distance from abutment top to mucosal margin
|
at 2 months (2M), 3 months (3ML), and 6 months after loading (6ML)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Probing pocket depth (PPD, mm)
Time Frame: 2 months(2M), 3- and 6- month loading(3ML, 6ML)
|
the pocket depth was measured with periodontal probe at 6 points around the implants
|
2 months(2M), 3- and 6- month loading(3ML, 6ML)
|
|
Marginal bone level (MBL, mm)
Time Frame: 3-month and 6 month loading(3ML, 6ML)
|
The distance from bone-implant contact to platform of the implant was evaluated ion peri-apical film
|
3-month and 6 month loading(3ML, 6ML)
|
|
Emergence profile
Time Frame: 3- month loading
|
The 3 restoration categories with straight, concave and convex.
|
3- month loading
|
|
Emergence angle (degree)
Time Frame: 3- month loading
|
the angle between the profile and long axis of implant
|
3- month loading
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 202100738A3D001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-implant Bone Level
-
NCT04385355RecruitingPeri-implant Marginal Bone Loss | Peri-implant Bone Level | Transmucosal Abutment Design | Peri-implant Bone Loss
-
NCT07584759CompletedMarginal Bone Loss | Peri-implant Marginal Bone Loss | Peri-implant Bone Loss | Peri-Implant Health
-
NCT07089407CompletedPeri-implant Bone Loss | Peri-Implant Tissues
-
NCT07637864Active, not recruitingDental Implants | Early Peri-Implant Bone Remodeling | Peri-Implant Soft Tissue Remodeling
-
NCT07588789Active, not recruitingDental Implant Bone Loss | Peri-Implant Health
-
NCT06720389CompletedPeri Implant Bone Loss
-
NCT01245920WithdrawnPeri-implant Alveolar Bone Thickness
-
NCT07557836CompletedImplant Stability | Partially Edentulous Patients | Peri-implant Marginal Bone Loss
-
NCT04761445CompletedImplant Stability | Peri-implant Bone Loss | Vertical Soft Tissue Thickness
-
NCT07156799CompletedPeri-implant Bone Healing and Osseointegration
Clinical Trials on APF + FGG
-
NCT06737120Not yet recruitingGingival Recession, Localized | Free Gingival Graft | Keratinized Tissue
-
NCT06294587RecruitingRidge Augmentation | Alveolar Mucosa
-
NCT07496437Not yet recruitingTooth Extraction | Alveolar Bone Resorption | Hyaluronic Acid | Alveolar Ridge Enlargement
-
NCT07595211Not yet recruiting
-
NCT04822311CompletedDepression | Brain Injuries | Acute Pain | Chronic Pain Due to Injury
-
NCT07308808RecruitingNeurogenic Bladder | Spinal Cord Injuries (SCI) | Urinary Tract Infection (Diagnosis)
-
NCT01547962Completed
-
NCT07655349RecruitingTo Clinically Compare Post-operative Pain Between Free Gingival Grafts Stabilization Around Natural Teeth Using Titanium Tacks vs Suturing Technique
-
NCT06694623Completed
-
NCT07409558RecruitingGingival Recession, Localized | Soft Tissue Volume Changes | Keratinized Tissue Deficiency